James Michael Campbell, M.D.
Internal Medicine, Cardiovascular Disease (M.D.) in Huntsville, Alabama, trained at University of Alabama School of Medicine (class of 1984). Their prescriptions cost Medicare Part D more than their services did: $790,080 for 3,352 claims, against $479,683 paid for services in 2024. Novartis Pharmaceuticals Corporation was the largest of 9 companies reporting payments in 2025, $502.19 in all, mostly food and beverage. A record with the same name and state is on the OIG exclusion list; it carries no NPI, so check it before acting.
Overview
| NPI | 1144290982 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Jan 24, 2006 |
| Last updated in NPPES | May 19, 2009 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Cardiovascular Disease Primary | 207RC0000X | 12076 | AL |
Exclusion screening
Possible match: verify before acting. The OIG list has a record with the same name in Alabama, but that record carries no NPI, so it may be a different person or business.
| Matched by | Name on OIG list | Exclusion type | Excluded since | Location |
|---|---|---|---|---|
| Name + state | James A. Campbell · Pharmacist | 1128a1 | Jul 3, 1997 | Valley, AL |
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | Possible (name) | See above |
| North Carolina Medicaid · Nov 4, 2026 | No match | — |
| New York OMIG · Nov 4, 2026 | No match | — |
| Ohio Medicaid · Nov 4, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 4, 2026 | No match | — |
| Washington HCA · Nov 4, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Cardiovascular Disease (Cardiology) (AL) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 762 |
|---|---|
| Services billed | 4,444 across 42 procedure codes |
| Paid by Medicare | $479,683 |
Part D prescriptions in 2024
| Prescriptions (claims) | 3,352 · 8,304 30-day fills |
|---|---|
| Patients | 472 |
| Total drug cost | $790,080 |
| Generic share | 77% of claims |
Education and affiliations
| Medical school | University of Alabama School of Medicine |
|---|---|
| Graduation year | 1984 |
| Medicare specialty | Cardiovascular Disease (Cardiology) |
| Secondary specialties | Internal Medicine |
Medical group
- Huntsville Cardiovascular Clinic, P. C.Huntsville, AL · 17 clinicians
Hospital affiliations
- Athens Limestone HospitalAthens, AL
- Crestwood Medical CenterHuntsville, AL
- Huntsville HospitalHuntsville, AL
- Marshall Medical CentersBoaz, AL
Industry payments (Open Payments)
- 2025$502.19 · 26 payments from 9 companies
- 2024$493.36 · 31 payments from 11 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Novartis Pharmaceuticals Corporation | $120.53 | 6 |
| E.R. Squibb & Sons, L.L.C. | $92.74 | 5 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $79.27 | 5 |
| Novo Nordisk Inc | $67.87 | 4 |
| Merck Sharp & Dohme LLC | $47.07 | 2 |
What the 2025 payments were for
- Food and Beverage$502.19 · 26 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Cardiovascular Disease providers in Huntsville
- 1023177433
- 1376113902
- 1902521693
- 1386615078
- 1750515201
- 1356865216
- 1962579888
- 1811044605
- 1003187642
- 1831552751
- 1700856531
- 1316917156
All Internal Medicine, Cardiovascular Disease providers in Alabama →